Grant

Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)

CountryUnited States
Deadline2027-10-28 (340 days left)
Published2026-09-30
SectorsHealth & life sciences
SourceGrants.gov (US)

Summary

Funding opportunity RFA-MH-27-125. CFDA: 93.853, 93.242, 93.279

The buyer, the value, the full description and the link to the official notice are available with a free account.